This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Zymeworks Bc Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Patrick Kaminker
Introduction
Patrick Kaminker is a notable inventor based in Seattle, WA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work primarily focuses on the use of bispecific antigen-binding constructs for therapeutic applications.
Latest Patents
Kaminker holds a patent titled "Methods of using a bispecific antigen-binding construct targeting HER2 for the treatment of biliary tract cancers." This patent describes a method of treating biliary tract cancer (BTC) by administering a bispecific antigen-binding construct that targets HER2 or a construct linked to an auristatin analogue (ADC) to a subject. This innovative approach has the potential to improve treatment outcomes for patients suffering from this challenging form of cancer. He has 1 patent to his name.
Career Highlights
Patrick Kaminker is currently associated with Zymeworks BC Inc., where he continues to advance his research in cancer therapies. His work at Zymeworks has positioned him as a key player in the development of novel treatment strategies.
Collaborations
Kaminker collaborates with esteemed colleagues, including Diana F Hausman and Neil C Josephson, who contribute to his research endeavors and help drive innovation in the field.
Conclusion
Patrick Kaminker's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his commitment to advancing medical science. His work continues to inspire and pave the way for future breakthroughs in oncology.